Form 8-K - Current report:
SEC Accession No. 0001390478-14-000049
Filing Date
2014-09-18
Accepted
2014-09-18 16:45:51
Documents
2
Period of Report
2014-09-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gale-201409188xk.htm 8-K 42845
2 EXHIBIT exhibit101-markwschwartzph.htm EX-10.1 88716
  Complete submission text file 0001390478-14-000049.txt   133102
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33958 | Film No.: 141110389
SIC: 2834 Pharmaceutical Preparations